Temozolomide News and Research

RSS
Japanese researchers find new way for increasing effectiveness of drug delivery to brain tumors

Japanese researchers find new way for increasing effectiveness of drug delivery to brain tumors

New compound takes positive step toward creating drug for melanoma

New compound takes positive step toward creating drug for melanoma

UAB spinoff develops drug-resistant immunotherapy to combat solid tumors

UAB spinoff develops drug-resistant immunotherapy to combat solid tumors

Vaccine-chemotherapy combination may improve survival for glioblastoma patients

Vaccine-chemotherapy combination may improve survival for glioblastoma patients

New clinical approach offers hope for patients with aggressive brain cancer

New clinical approach offers hope for patients with aggressive brain cancer

Combined therapy extends survival of older patients with glioblastoma, clinical study shows

Combined therapy extends survival of older patients with glioblastoma, clinical study shows

TGen scientists identify potent inhibitory compound for treatment against glioblastoma

TGen scientists identify potent inhibitory compound for treatment against glioblastoma

Chemotherapy-induced senescent cells promote side effects and cancer relapse

Chemotherapy-induced senescent cells promote side effects and cancer relapse

Localized chemotherapy may be effective way to keep immune system intact, animal study suggests

Localized chemotherapy may be effective way to keep immune system intact, animal study suggests

Study addresses cost-effectiveness of checkpoint inhibitors for advanced melanoma in Hong Kong

Study addresses cost-effectiveness of checkpoint inhibitors for advanced melanoma in Hong Kong

Four miRNAs may hold vital clue to disease progression in gliobastoma

Four miRNAs may hold vital clue to disease progression in gliobastoma

Giving chemotherapy after radiotherapy delays rare brain tumour growth

Giving chemotherapy after radiotherapy delays rare brain tumour growth

Clinical trials of anti-cancer agent PAC-1 continue to progress with anonymous funding

Clinical trials of anti-cancer agent PAC-1 continue to progress with anonymous funding

Small lipid nanocarrier may deliver chemotherapeutic drug more efficiently to brain tumor cells

Small lipid nanocarrier may deliver chemotherapeutic drug more efficiently to brain tumor cells

DelMar's VAL-083 receives FDA orphan drug designation for treatment of medulloblastoma

DelMar's VAL-083 receives FDA orphan drug designation for treatment of medulloblastoma

Expression of BIRC3 protein associated with poor survival, recurrent disease in GBM patients

Expression of BIRC3 protein associated with poor survival, recurrent disease in GBM patients

New clinical trial launched to test potential drug that could help immune system combat cancer

New clinical trial launched to test potential drug that could help immune system combat cancer

Use of tumor-treating fields along with chemotherapy improves survival in patients with brain tumor

Use of tumor-treating fields along with chemotherapy improves survival in patients with brain tumor

Scientists identify way to sensitize drug-resistant glioblastoma cells to chemotherapy

Scientists identify way to sensitize drug-resistant glioblastoma cells to chemotherapy

TGen: PPF drug could help treat patients with deadly brain cancer

TGen: PPF drug could help treat patients with deadly brain cancer